BNGO News and Press, Bionano Genomics Inc. From 01/26/21

SAN DIEGO, Jan. 26, 2021 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) announced the release of version 1.2 of its Compute On Demand (COD) cloud compute solution which significantly reduces the cost and time to analyze structural variants (SVs) in a human genome. This update is ...

Shares of Bionano Genomics (NASDAQ: BNGO) furthered their recent gains on Monday. By the close of trading, the genome analysis company's stock price was up 28.4%. Bullish analyst remarks have likely contributed to Bionano's recent ascent. Maxim analyst Jason McCarthy reiterated ...

Gainers: VYNE Therapeutics (VYNE) +33%, Evolus (EOLS) +33%, Accelerate Diagnostics (AXDX) +32%, Atossa Therapeutics (ATOS) +29%, Bionano Genomics (BNGO) +27%.Losers: Neuronetics (STIM) -14%, Akerna (KERN) -10%, Precigen (PGEN) -9%,&#...

SAN DIEGO, Jan. 25, 2021 (GLOBE NEWSWIRE) -- BIONANO GENOMICS, INC. (Nasdaq: BNGO), announced today the closing of its previously announced underwritten public offering of 38,333,352 shares of its common stock, including 5,000,002 shares sold pursuant to the underwriters’ exerci...

Shares of Bionano Genomics (NASDAQ: BNGO) , a genome analysis specialist, have been on fire of late, skyrocketing by more than 1,500% over the past month. On Friday, the company extended that upward run: Its stock was up by 12% as of 1:33 p.m. EST, after jumping by as much as 16.7% ...

Shares of Bionano Genomics (NASDAQ: BNGO) fell on Wednesday after the genome-analysis company announced the pricing of its public stock offering. As of 12:30 p.m. EST, Bionano's stock price was down 13%. Bionano expects to raise roughly $200 million via the sale of 33,333,350 sh...

Gainers: Obalon Therapeutics (OBLN) +438%.Caladrius Biosciences (CLBS) +121%.Adamis Pharmaceuticals (ADMP) +72%.Steel Connect (STCN) +54%.Titan Medical (TMDI) +52%.Tiziana Life Sciences (TLSA) +50%.Iterum Therapeutics (ITRM) +40%.Dare Bioscience (DARE) +33%.17 Education & T...

Document Security Systems (DSS) -31% on stock offering.Gevo (GEVO) -25% on stock offering.BioLineRx (BLRX) -22% on equity offering.Bionano Genomics (BNGO) -19% on pricing of stock offering.Histogen (HSTO) -12% on FDA clinical hold of planned study for HST-003.AcelRx P...

Bionano Genomics (BNGO) slumped 23% in premarket trade after pricing its earlier announced underwritten public offering of 33.3M shares at $6/share; underwriters granted 30-day option to purchase up to an additional 5M shares to cover over-allotments.Offering expected to close on Ja...

SAN DIEGO, Jan. 20, 2021 (GLOBE NEWSWIRE) -- BIONANO GENOMICS, INC. (Nasdaq: BNGO), announced today the pricing of its previously announced underwritten public offering of 33,333,350 shares of its common stock at a price to the public of $6.00 per share. The gross proceeds to Bionano f...